La bourse est fermée

Medtronic plc (MDT)

NYSE - Nasdaq Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
108,55-0,23 (-0,21 %)
À la clôture : 04:00PM EST
107,17 -1,38 (-1,27 %)
Échanges après Bourse : 07:56PM EST

Medtronic plc

20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
https://www.medtronic.com

Secteur(s)Healthcare
Secteur d’activitéMedical Devices
Employés à temps plein90 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Geoffrey Straub MarthaChairman & CEO4,09M776,81k1970
Ms. Karen L. ParkhillEVP, CFO, IT & Enterprise Excellence3,29MS.O.1965
Dr. Richard E. Kuntz M.D., M.Sc.Sr. VP and Chief Medical & Scientific Officer2,61MS.O.1957
Mr. Bradley E. LermanSr. VP, Gen. Counsel & Corp. Sec.2,83M2,02M1956
Mr. Robert John WhiteExec. VP & Pres of Medical Surgical Portfolio2,66MS.O.1963
Mr. Mark PloofSr. VP of Global Operations and Bus. ServicesS.O.S.O.S.O.
Ms. Jennifer M. KirkPrincipal Accounting Officer, Global Controller & Chief Accounting OfficerS.O.S.O.1975
Mr. Sean LennonChief Information OfficerS.O.S.O.S.O.
Mr. Ryan WeispfenningVP of Investor RelationsS.O.S.O.S.O.
Mr. Torod B. NeptuneSr. VP & Chief Communications OfficerS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Medtronic plc en date du 26 septembre 2021 est 6. Les scores principaux sont Audit : 8; Société : 8; Droits des actionnaires : 6; Compensation : 4.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.